رجوع
34
1
نطاق اليوم
KWD 12.42
KWD 12.84
نطاق 52 أسبوعًا
KWD 12.42
KWD 18.00
حجم التداول
1
متوسط 50 يوم / 200 يوم
KWD 15.17
/
KWD 15.98
الإغلاق السابق
KWD 12.42
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 7.7 | 3.7 |
| Net Margin % | 13.5 | 3.9 |
| Rev Growth 5Y % | 9.0 | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 158.556
KWD 154.184 – KWD 163.816
|
590 B | 1 |
| FY2029 |
KWD 170.947
KWD 166.233 – KWD 176.617
|
590 B | 1 |
| FY2028 |
KWD 153.159
KWD 148.936 – KWD 158.240
|
540 B | 2 |
النقاط الرئيسية
Revenue grew 9.00% annually over 5 years — modest growth
Debt/Equity of 0.00 — conservative balance sheet
Generating 58.96B in free cash flow
P/E of 0.10 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.66%
Cash machine — converts 87.86% of earnings into free cash flow
النمو
Revenue Growth (5Y)
9.00%
Revenue (1Y)0.34%
Earnings (1Y)12.07%
FCF Growth (3Y)-15.57%
الجودة
Return on Equity
7.69%
ROIC8.59%
Net Margin13.49%
Op. Margin20.59%
الأمان
Debt / Equity
0.00
Current Ratio2.72
Interest Coverage28.07
التقييم
P/E Ratio
0.10
P/B Ratio0.01
EV/EBITDA-2.08
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.34% | Revenue Growth (3Y) | 6.04% |
| Earnings Growth (1Y) | 12.07% | Earnings Growth (3Y) | -9.09% |
| Revenue Growth (5Y) | 9.00% | Earnings Growth (5Y) | 6.40% |
| Profitability | |||
| Revenue (TTM) | 497.26B | Net Income (TTM) | 67.10B |
| ROE | 7.69% | ROA | 6.05% |
| Gross Margin | 74.25% | Operating Margin | 20.59% |
| Net Margin | 13.49% | Free Cash Flow (TTM) | 58.96B |
| ROIC | 8.59% | FCF Growth (3Y) | -15.57% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 2.72 |
| Interest Coverage | 28.07 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.10 | P/B Ratio | 0.01 |
| P/S Ratio | 0.01 | PEG Ratio | 1.45 |
| EV/EBITDA | -2.08 | Dividend Yield | 0.02% |
| Market Cap | 6.50B | Enterprise Value | -212.46B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 497.26B | 495.56B | 442.23B | 398.37B | 352.25B |
| Net Income | 67.10B | 59.87B | 81.19B | 53.57B | 52.35B |
| EPS (Diluted) | 128.18 | 113.06 | 151.01 | 99.66 | 97.39 |
| Gross Profit | 369.21B | 362.95B | 331.03B | 311.46B | 264.40B |
| Operating Income | 102.36B | 91.87B | 86.44B | 82.37B | 61.17B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.11T | 1.07T | 1.03T | 939.88B | 921.87B |
| Total Liabilities | 214.72B | 216.55B | 189.52B | 177.06B | 184.71B |
| Shareholders' Equity | 894.11B | 850.81B | 836.42B | 762.83B | 737.16B |
| Total Debt | 0.0 | 0.0 | 19.30B | 21.64B | 22.54B |
| Cash & Equivalents | 218.96B | 244.68B | 403.08B | 339.19B | 335.08B |
| Current Assets | 493.78B | 504.03B | 611.12B | 542.19B | 518.23B |
| Current Liabilities | 181.24B | 164.68B | 133.24B | 109.83B | 109.13B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#587 of 820
#687 of 708
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026